Man Group »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Man Group

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Man Group from 13F filings

Historical chart of Man Group investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Man Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Man Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.6M 3.8M 0.93
2023-09-30 $3.6M 3.9M 0.94

More positions owned by Man Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Coca-Cola Company (KO)
Anthem (ELV)
Qualcomm (QCOM)
Newmont Mining Corporation (NEM)
Intel Corporation (INTC)
Adobe Systems Incorporated (ADBE)

View all positions for Man Group

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1